Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for enhancing immunosuppressive therapy by multiple administration of αβTCR-binding polypeptide

Methods for enhancing immunosuppressive therapy by multiple administration of αβTCR-binding polypeptide

US Patent 11142575 · Granted Oct 12, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αβTCR antibody2021
Anti-αβTCR antibody2021
Anti-αβTCR antibody2021
Anti-αβTCR antibody2018
Anti-αβTCR antibody2018
Anti-αβTCR antibody2018
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2016
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2014
Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and 2010
Identification and characterization of function-blocking anti-ED-B-fibronectin a2010
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines2009
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines2009